Cannabis Bioscience International Holdings, Inc. (CBIH) Notes Payables (2023 - 2025)
Cannabis Bioscience International Holdings (CBIH) posted Notes Payables of $111721.0 for Q4 2025, up 1655.79% sequentially from $6363.0 in Q3 2025, and down 0.81% YoY from $112629.0 in Q4 2024.
Cannabis Bioscience International Holdings, Inc. (CBIH) Notes Payables (2023 - 2025) Analysis & Trends
Cannabis Bioscience International Holdings has reported Notes Payables for 3 years, with the latest figure at $111721.0 in Q4 2025.
- Quarterly Notes Payables fell 0.81% year-over-year to $111721.0 in Q4 2025, while the trailing twelve-month figure through Nov 2025 was $111721.0 (down 0.81% YoY) and the FY2025 annual result came in at $9182.0, changed N/A from the prior year.
- Notes Payables advanced to $111721.0 in Q4 2025 per CBIH's latest filing, from $6363.0 in the prior quarter.
- Over five years, Notes Payables peaked at $151267.0 in Q4 2023 and troughed at $5485.0 in Q1 2024.
- A 3-year average of $83935.8 and a median of $112629.0 in 2024 frame the typical range for Notes Payables.
- The widest YoY moves for Notes Payables: up 2174.18% in 2025, down 94.35% in 2025.
- Over 3 years, Notes Payables stood at $151267.0 in 2023, then declined by 25.54% to $112629.0 in 2024, then declined by 0.81% to $111721.0 in 2025.
- According to Business Quant data, Notes Payables over the past three periods registered $111721.0, $6363.0, and $9182.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2025 | 111,721.00 |
| Aug 31, 2025 | 6,363.00 |
| May 31, 2025 | 9,182.00 |
| Feb 28, 2025 | 124,739.00 |
| Nov 30, 2024 | 112,629.00 |
| Aug 31, 2024 | 112,629.00 |
| Feb 29, 2024 | 5,485.00 |
| Nov 30, 2023 | 151,267.00 |
| May 31, 2023 | 121,407.00 |